The analysis of clinical, functional and hemodynamic characteristics of PAH patients revealed that patients carriers of a BMPR2 or an ACVRL1 mutation are younger at diagnosis than patients with idiopathic PAH. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.